PRIMARY Ancillary Substudy

Recruiting now · Not applicable

Conditions studied: Mitral Valve Prolapse, Left Ventricular Fibrosis, Ventricular Arrhythmias

In brief

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.

Key facts

Study ID
NCT07103733
Run by
Annetine Gelijns
People needed
250
Starts
2023-10-16
Expected to finish
2027-06-30
Last updated by the study team
2025-08-19

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.